TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 78 filers reported holding TRINITY BIOTECH PLC in Q1 2016. The put-call ratio across all filers is 5.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $753,000 | -66.0% | 108,812 | -32.5% | 1.71% | -69.2% |
Q3 2016 | $2,215,000 | +21.1% | 161,284 | 0.0% | 5.56% | +29.6% |
Q2 2016 | $1,829,000 | -2.8% | 161,284 | 0.0% | 4.29% | -0.8% |
Q1 2016 | $1,881,000 | -7.8% | 161,284 | -7.0% | 4.33% | -40.9% |
Q4 2015 | $2,040,000 | – | 173,427 | – | 7.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |